Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinidazole for Radical Cure of Plasmodium Vivax
NCT00811096Phase 2Completed
- Sponsor
- Walter Reed Army Institute of Research
- Start
- Nov 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tinidazole in Plasmodium vivax malaria (2 arms), sponsored by Walter Reed Army Institute of Research. Primary endpoint: Cure (Absence of Malaria Infection) at 63 days. Started Nov 2008; status: completed.
02
Drugs
tinidazole
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT00811096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811096.